Patent No. EP2658542 (titled "Topical Localized Isoxazoline Formulation") was filed by Intervet on Dec 22, 2011. The application was issued on Jun 4, 2025.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| VIRBAC | Oct 25, 2022 | GEVERS & ORES |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
May 9, 2025
May 9, 2025
Apr 24, 2025
Apr 24, 2025
Apr 24, 2025
Apr 24, 2025
Apr 24, 2025
Mar 12, 2025
Mar 12, 2025
Mar 12, 2025
Mar 7, 2025
Feb 19, 2025
Nov 19, 2024
Nov 19, 2024
Nov 19, 2024
Nov 19, 2024
Nov 19, 2024
Nov 19, 2024
Nov 19, 2024
Nov 19, 2024
Oct 30, 2024
Oct 30, 2024
Oct 24, 2024
Oct 23, 2024
Oct 23, 2024
Oct 23, 2024
Oct 23, 2024
Oct 23, 2024
Oct 23, 2024
Oct 23, 2024
Oct 10, 2024
Oct 10, 2024
Sep 16, 2024
Sep 16, 2024
Sep 10, 2024
Sep 10, 2024
Sep 10, 2024
Sep 10, 2024
Sep 10, 2024
Sep 10, 2024
Sep 10, 2024
Sep 10, 2024
Feb 29, 2024
Feb 29, 2024
Feb 29, 2024
Feb 29, 2024
Feb 29, 2024
Feb 29, 2024
Feb 29, 2024
Nov 8, 2023
Nov 2, 2023
Nov 2, 2023
Nov 2, 2023
Nov 2, 2023
Nov 2, 2023
Mar 22, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Mar 17, 2023
Nov 8, 2022
Nov 8, 2022
Oct 31, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Oct 25, 2022
Feb 8, 2022
Jan 7, 2022
Dec 17, 2021
Dec 17, 2021
Dec 17, 2021
Dec 17, 2021
Dec 17, 2021
Oct 21, 2021
Oct 21, 2021
Oct 21, 2021
Oct 21, 2021
Oct 21, 2021
Aug 17, 2021
Aug 17, 2021
Aug 17, 2021
Aug 17, 2021
Aug 17, 2021
Aug 17, 2021
Aug 17, 2021
Apr 28, 2021
Apr 28, 2021
Feb 6, 2019
Feb 6, 2019
Feb 6, 2019
Feb 6, 2019
Feb 6, 2019
Oct 23, 2018
Oct 23, 2018
Oct 16, 2018
Jul 16, 2018
Jul 17, 2015
Jul 13, 2015
Jan 30, 2014
Jan 30, 2014
Jan 30, 2014
Oct 9, 2013
Aug 8, 2013
Aug 6, 2013
Aug 6, 2013
Aug 6, 2013
Aug 6, 2013
Aug 6, 2013
Aug 1, 2013
Jul 17, 2013
May 27, 2013
May 27, 2013
May 27, 2013
May 13, 2013
Nov 15, 2012
Nov 15, 2012
Sep 4, 2012
Sep 4, 2012
Sep 4, 2012
Jul 25, 2012
Jul 25, 2012
Jul 5, 2012
Dec 22, 2011
Dec 22, 2011
Dec 22, 2011
Dec 22, 2011
Dec 22, 2011
Dec 22, 2011
Dec 22, 2011